Completed NA INTERVENTIONAL NCT00004433

Randomized Study of Pergolide in Children With Tourette Syndrome

Sponsor: Children's Hospital Medical Center, Cincinnati

Interventions pergolide

Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Dec 31, 1994 Completion: Sep 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004433, this NA trial focuses on Tourette Syndrome and remains completed. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 5 times since 1994, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Medical Center, Cincinnati

Data source: FDA Office of Orphan Products Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.